Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
January-2022 Volume 23 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2022 Volume 23 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

HIF‑1α mediates the protective effect of plasma extracellular particles induced by remote ischaemic preconditioning on oxidative stress injury in human umbilical vein endothelial cells

  • Authors:
    • Minghua Wen
    • Feng Hu
    • Zhijian Gong
    • Chahua Huang
    • Xiaoshu Cheng
  • View Affiliations / Copyright

    Affiliations: Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China
    Copyright: © Wen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 48
    |
    Published online on: November 15, 2021
       https://doi.org/10.3892/etm.2021.10970
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Remote ischaemic preconditioning (RIPC) is considered to alleviate myocardial ischaemia/reperfusion (I/R) injury. The present study explored whether blood plasma particulate matter, which is termed extracellular particles (EPs), and is released from cells during RIPC, could reduce H2O2‑induced damage in human umbilical vein endothelial cells (HUVECs). Firstly, EPs were derived from volunteers who did or did not undergo RIPC. To induce RIPC in volunteers, a blood pressure cuff was alternatively inflated for 5 min and deflated for the same duration for four successive cycles. HUVECs were assigned to two groups: i) Group 1 was preincubated for 24 h with EPs from volunteers after sham‑RIPC, then treated with H2O2 (1 mM; 6 h) to mimic the in vivo conditions of I/R‑induced oxidative stress; and ii) group 2 was preincubated for 24 h with EPs from volunteers after RIPC, then treated with H2O2. Subsequently, EPs were derived from rats received sham‑RIPC or RIPC and/or cadmium (Cd) pre‑treatment. To induce RIPC in rats, a remote hind limb preconditioning stimulus was delivered using a blood pressure cuff attached at the inguinal level of the rat. The blood pressure cuff was alternatively inflated for 5 min and deflated for the same time period for four successive cycles. HUVECs were assigned to six groups: i) Group 1 was untreated; ii) group 2 received only H2O2 treatment (1 mM; 6 h); iii) group 3 was preincubated for 24 h with EPs from rats exposed to sham‑RIPC, then treated with H2O2; iv) group 4 was preincubated for 24 h with EPs from rats that received an intraperitoneal injection of 1 mg/kg Cd [a pharmacological inhibitor of hypoxia‑inducible factor 1‑α (HIF‑1α) in vivo] 180 min before sham‑RIPC, then treated with H2O2; v) group 5 was preincubated for 24 h with EPs from rats exposed to RIPC, then treated with H2O2; and vi) group 6 was preincubated for 24 h with EPs from rats that received an intraperitoneal injection of 1 mg/kg Cd 180 min before RIPC, then treated with H2O2. Cell viability and cytotoxicity were monitored using Cell Counting Kit‑8 and lactate dehydrogenase assays. Cell apoptosis and necrosis were assessed via flow cytometry and western blot analysis. A notable increase in EP concentration in the plasma of volunteers after RIPC compared with that in the plasma of volunteers after sham‑RIPC was observed. RIPC‑associated EPs (RIPC‑EPs) from volunteers could improve cell viability and reduce cytotoxicity, cell apoptosis and necrosis in HUVECs treated with H2O2 in vitro. Furthermore, RIPC caused a significant increase in HIF‑1α expression in the rat limb musculature. The apoptosis‑reducing effect of RIPC‑EPs was demonstrated to be counteracted by an intraperitoneal injection of Cd before RIPC in rats. A significant decrease in the EP levels precipitated from the plasma of rats that received Cd treatment before RIPC was observed compared with rats that did not receive Cd treatment. The present study suggested that HIF‑1α mediated at least partly the protective effect of plasma RIPC‑EPs on oxidative stress injury in HUVECs.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Hausenloy DJ and Yellon DM: Remote ischaemic preconditioning: Underlying mechanisms and clinical application. Cardiovasc Res. 79:377–386. 2008.PubMed/NCBI View Article : Google Scholar

2 

Gho BC, Schoemaker RG, van den Doel MA, Duncker DJ and Verdouw PD: Myocardial protection by brief ischemia in noncardiac tissue. Circulation. 94:2193–2200. 1996.PubMed/NCBI View Article : Google Scholar

3 

Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H and Thielmann M: STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: Short communication. Circ Res. 110:111–115. 2012.PubMed/NCBI View Article : Google Scholar

4 

Kttenberg E, Thielmann M, Bergmann L, Heine T, Jakob H, Heusch G and Peters J: Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol-a clinical trial. Acta Anaesthesiol Scand. 56:30–38. 2012.PubMed/NCBI View Article : Google Scholar

5 

Ali ZA, Callaghan CJ, Lim E, Ali AA, Nouraei SA, Akthar AM, Boyle JR, Varty K, Kharbanda RK, Dutka DP and Gaunt ME: Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: A randomized controlled trial. Circulation. 116 (Suppl 11):I98–I105. 2007.PubMed/NCBI View Article : Google Scholar

6 

Kharbanda RK, Nielsen TT and Redington AN: Translation of remote ischaemic preconditioning into clinical practice. Lancet. 374:1557–1565. 2009.PubMed/NCBI View Article : Google Scholar

7 

Bøtker HE, Lassen TR and Jespersen NR: Clinical translation of myocardial conditioning. Am J Physiol Heart Circ Physiol. 314:H1225–H1252. 2018.PubMed/NCBI View Article : Google Scholar

8 

Abel F, Murke F, Gaida M, Garnier N, Ochsenfarth C, Theiss C, Thielmann M, Kleinbongard P, Giebel B, Peters J and Frey UH: Extracellular vesicles isolated from patients undergoing remote ischemic preconditioning decrease hypoxia-evoked apoptosis of cardiomyoblasts after isoflurane but not propofol exposure. PLoS One. 15(e0228948)2020.PubMed/NCBI View Article : Google Scholar

9 

Frey UH, Klaassen M, Ochsenfarth C, Murke F, Thielmann M, Kottenberg E, Kleinbongard P, Klenke S, Engler A, Heusch G, et al: Remote ischaemic preconditioning increases serum extracellular vesicle concentrations with altered micro-RNA signature in CABG patients. Acta Anaesthesiol Scand. 63:483–492. 2019.PubMed/NCBI View Article : Google Scholar

10 

Bartekova M, Jelemensky M and Dhalla NS: Emerging role of non-coding RNAs and extracellular vesicles in cardioprotection by remote ischemic conditioning of the heart. Rev Cardiovasc Med. 20:59–71. 2019.PubMed/NCBI View Article : Google Scholar

11 

Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A and Ratajczak MZ: Membrane-derived microvesicles: Important and underappreciated mediators of cell-to-cell communication. Leukemia. 20:1487–1495. 2006.PubMed/NCBI View Article : Google Scholar

12 

Colombo M, Raposo G and Théry C: Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 30:255–289. 2014.PubMed/NCBI View Article : Google Scholar

13 

Raposo G and Stoorvogel W: Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol. 200:373–383. 2013.PubMed/NCBI View Article : Google Scholar

14 

Semenza GL: A compendium of proteins that interact with HIF-1α. Exp Cell Res. 356:128–135. 2017.PubMed/NCBI View Article : Google Scholar

15 

Aga M, Kondo S, Wakisaka N, Moriyama-Kita M, Endo K, Nakanishi Y, Murono S, Sugimoto H, Ueno T and Yoshizaki T: Siah-1 is associated with expression of hypoxia-inducible factor-1α in oral squamous cell carcinoma. Auris Nasus Larynx. 44:213–219. 2017.PubMed/NCBI View Article : Google Scholar

16 

Kosaka N, Iguchi H, Hagiwara K, Yoshioka Y, Takeshita F and Ochiya T: Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J Biol Chem. 288:10849–10859. 2013.PubMed/NCBI View Article : Google Scholar

17 

Hubbi ME and Semenza GL: Regulation of cell proliferation by hypoxia-inducible factors. Am J Physiol Cell Physiol. 309:C775–C782. 2015.PubMed/NCBI View Article : Google Scholar

18 

Cai Z, Luo W, Zhan H and Semenza GL: Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart. Proc Natl Acad Sci USA. 110:17462–17467. 2013.PubMed/NCBI View Article : Google Scholar

19 

Seal JB and Gewertz BL: Vascular dysfunction in ischemia/reperfusion injury. Ann Vasc Surg. 19:572–584. 2005.PubMed/NCBI View Article : Google Scholar

20 

Michiels C: Endothelial cell functions. J Cell Physiol. 196:430–443. 2003.PubMed/NCBI View Article : Google Scholar

21 

Pitcher JM, Wang M, Tsai BM, Kher A, Turrentine MW, Brown JW and Meldrum DR: Preconditioning: Gender effects. J Surg Res. 129:202–220. 2005.PubMed/NCBI View Article : Google Scholar

22 

Kharbanda RK, Peters M, Walton B, Kattenhorn M, Mullen M, Klein N, Vallance P, Deanfield J and MacAllister R: Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation. 103:1624–1630. 2001.PubMed/NCBI View Article : Google Scholar

23 

Randhawa PK and Jaggi AS: Exploring the putative role of TRPV1-dependent CGRP release in remote hind preconditioning-induced cardioprotection. Cardiovasc Ther. 35:2017.PubMed/NCBI View Article : Google Scholar

24 

Yamaguchi T, Izumi Y, Nakamura Y, Yamazaki T, Shiota M, Sano S, Tanaka M, Osada-Oka M, Shimada K, Miura K, et al: Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction. Int J Cardiol. 178:239–246. 2015.PubMed/NCBI View Article : Google Scholar

25 

Sera T, Kohno T, Nakashima Y, Uesugi M and Kudo S: Low-frequency oscillations of finger skin blood flow during the initial stage of cold-induced vasodilation at different air temperatures. J Physiol Anthropol. 39(37)2020.PubMed/NCBI View Article : Google Scholar

26 

Yang Y, Li Y, Chen X, Cheng X, Liao Y and Yu X: Exosomal transfer of miR-30a between cardiomyocytes regulates autophagy after hypoxia. J Mol Med (Berl). 94:711–724. 2016.PubMed/NCBI View Article : Google Scholar

27 

Jiang F, Xu XR, Li WM, Xia K, Wang LF and Yang XC: Monotropein alleviates H2O2-induced inflammation, oxidative stress and apoptosis via NF-κB/AP-1 signaling. Mol Med Rep. 22:4828–4836. 2020.PubMed/NCBI View Article : Google Scholar

28 

Belaidi E, Beguin PC, Levy P, Ribuot C and Godin-Ribuot D: Prevention of HIF-1 activation and iNOS gene targeting by low-dose cadmium results in loss of myocardial hypoxic preconditioning in the rat. Am J Physiol Heart Circ Physiol. 294:H901–H908. 2008.PubMed/NCBI View Article : Google Scholar

29 

Belaidi E, Beguin PC, Levy P, Ribuot C and Godin-Ribuot D: Delayed myocardial preconditioning induced by cobalt chloride in the rat: HIF-1α and iNOS involvement. Fundam Clin Pharmacol. 26:454–462. 2012.PubMed/NCBI View Article : Google Scholar

30 

Kalakech H, Tamareille S, Pons S, Godin-Ribuot D, Carmeliet P, Furber A, Martin V, Berdeaux A, Ghaleh B and Prunier F: Role of hypoxia inducible factor-1α in remote limb ischemic preconditioning. J Mol Cell Cardiol. 65:98–104. 2013.PubMed/NCBI View Article : Google Scholar

31 

Chun YS, Choi E, Kim GT, Choi H, Kim CH, Lee MJ, Kim MS and Park JW: Cadmium blocks hypoxia-inducible factor (HIF)-1-mediated response to hypoxia by stimulating the proteasome-dependent degradation of HIF-1alpha. Eur J Biochem. 267:4198–4204. 2000.PubMed/NCBI View Article : Google Scholar

32 

Jungmann J, Reins HA, Schobert C and Jentsch S: Resistance to cadmium mediated by ubiquitin-dependent proteolysis. Nature. 361:369–371. 1993.PubMed/NCBI View Article : Google Scholar

33 

Liu L and Shi GP: CD31: Beyond a marker for endothelial cells. Cardiovasc Res. 94:3–5. 2012.PubMed/NCBI View Article : Google Scholar

34 

Sanada S, Komuro I and Kitakaze M: Pathophysiology of myocardial reperfusion injury: Preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol. 301:H1723–H1741. 2011.PubMed/NCBI View Article : Google Scholar

35 

Wang X, Zhu H, Zhang X, Liu Y, Chen J, Medvedovic M, Li H, Weiss MJ, Ren X and Fan GC: Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc Res. 94:379–390. 2012.PubMed/NCBI View Article : Google Scholar

36 

Wagner R, Piler P, Bedanova H, Adamek P, Grodecka L and Freiberger T: Myocardial injury is decreased by late remote ischaemic preconditioning and aggravated by tramadol in patients undergoing cardiac surgery: A randomised controlled trial. Interact Cardiovasc Thorac Surg. 11:758–762. 2010.PubMed/NCBI View Article : Google Scholar

37 

Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, Holtby HM, Cox PN, Smallhorn JF, Van Arsdell GS and Redington AN: Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: First clinical application in humans. J Am Coll Cardiol. 47:2277–2282. 2006.PubMed/NCBI View Article : Google Scholar

38 

Hausenloy DJ and Yellon DM: The therapeutic potential of ischemic conditioning: An update. Nat Rev Cardiol. 8:619–629. 2011.PubMed/NCBI View Article : Google Scholar

39 

Thielmann M, Wendt D, Tsagakis K, Price V, Dohle DS, Pasa S and Kottenberg E: Remote ischemic preconditioning: The surgeon's perspective. J Cardiovasc Med (Hagerstown). 14:187–192. 2013.PubMed/NCBI View Article : Google Scholar

40 

Veighey K and Macallister RJ: Clinical applications of remote ischemic preconditioning. Cardiol Res Pract. 2012(620681)2012.PubMed/NCBI View Article : Google Scholar

41 

Pickard JM, Davidson SM, Hausenloy DJ and Yellon DM: Co-dependence of the neural and humoral pathways in the mechanism of remote ischemic conditioning. Basic Res Cardiol. 111(50)2016.PubMed/NCBI View Article : Google Scholar

42 

Oba T, Yasukawa H, Nagata T, Kyogoku S, Minami T, Nishihara M, Ohshima H, Mawatari K, Nohara S, Takahashi J, et al: Renal nerve-mediated erythropoietin release confers cardioprotection during remote ischemic preconditioning. Circ J. 79:1557–1567. 2015.PubMed/NCBI View Article : Google Scholar

43 

Bromage DI, Davidson SM and Yellon DM: Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium. Pharmacol Ther. 143:305–315. 2014.PubMed/NCBI View Article : Google Scholar

44 

Rassaf T, Totzeck M, Hendgen-Cotta UB, Shiva S, Heusch G and Kelm M: Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning. Circ Res. 114:1601–1610. 2014.PubMed/NCBI View Article : Google Scholar

45 

Hibert P, Prunier-Mirebeau D, Beseme O, Chwastyniak M, Tamareille S, Lamon D, Furber A, Pinet F and Prunier F: Apolipoprotein A-I is a potential mediator of remote ischemic preconditioning. PLoS One. 8(e77211)2013.PubMed/NCBI View Article : Google Scholar

46 

Cai ZP, Parajuli N, Zheng X and Becker L: Remote ischemic preconditioning confers late protection against myocardial ischemia-reperfusion injury in mice by upregulating interleukin-10. Basic Res Cardiol. 107(277)2012.PubMed/NCBI View Article : Google Scholar

47 

Li J, Rohailla S, Gelber N, Rutka J, Sabah N, Gladstone RA, Wei C, Hu P, Kharbanda RK and Redington AN: MicroRNA-144 is a circulating effector of remote ischemic preconditioning. Basic Res Cardiol. 109(423)2014.PubMed/NCBI View Article : Google Scholar

48 

Abete P, Ferrara N, Cacciatore F, Madrid A, Bianco S, Calabrese C, Napoli C, Scognamiglio P, Bollella O, Cioppa A, et al: Angina-induced protection against myocardial infarction in adult and elderly patients: A loss of preconditioning mechanism in the aging heart? J Am Coll Cardiol. 30:947–954. 1997.PubMed/NCBI View Article : Google Scholar

49 

Ebrahim Z, Yellon DM and Baxter GF: Ischemic preconditioning is lost in aging hypertensive rat heart: Independent effects of aging and longstanding hypertension. Exp Gerontol. 42:807–814. 2007.PubMed/NCBI View Article : Google Scholar

50 

Ferdinandy P, Schulz R and Baxter GF: Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev. 59:418–458. 2007.PubMed/NCBI View Article : Google Scholar

51 

Babiker F, Al-Jarallah A and Al-Awadi M: Effects of cardiac hypertrophy, diabetes, aging, and pregnancy on the cardioprotective effects of postconditioning in male and female rats. Cardiol Res Pract. 2019(3403959)2019.PubMed/NCBI View Article : Google Scholar

52 

Weber NC, Riedemann I, Smit KF, Zitta K, van de Vondervoort D, Zuurbier CJ, Hollmann MW, Preckel B and Albrecht M: Plasma from human volunteers subjected to remote ischemic preconditioning protects human endothelial cells from hypoxia-induced cell damage. Basic Res Cardiol. 110(17)2015.PubMed/NCBI View Article : Google Scholar

53 

Albrecht M, Zitta K, Bein B, Wennemuth G, Broch O, Renner J, Schuett T, Lauer F, Maahs D, Hummitzsch L, et al: Remote ischemic preconditioning regulates HIF-1α levels, apoptosis and inflammation in heart tissue of cardiosurgical patients: A pilot experimental study. Basic Res Cardiol. 108(314)2013.PubMed/NCBI View Article : Google Scholar

54 

Hackenbeck T, Huber R, Schietke R, Knaup KX, Monti J, Wu X, Klanke B, Frey B, Gaipl U, Wullich B, et al: The GTPase RAB20 is a HIF target with mitochondrial localization mediating apoptosis in hypoxia. Biochim Biophys Acta. 1813:1–13. 2011.PubMed/NCBI View Article : Google Scholar

55 

Wang T, Gilkes DM, Takano N, Xiang L, Luo W, Bishop CJ, Chaturvedi P, Green JJ and Semenza GL: Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis. Proc Natl Acad Sci USA. 111:E3234–E3242. 2014.PubMed/NCBI View Article : Google Scholar

56 

Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP, et al: Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 12:19–30. 2010.PubMed/NCBI View Article : Google Scholar

57 

Ke Q and Costa M: Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol. 70:1469–1480. 2006.PubMed/NCBI View Article : Google Scholar

58 

Bao L, Chen Y, Lai HT, Wu SY, Wang JE, Hatanpaa KJ, Raisanen JM, Fontenot M, Lega B, Chiang CM, et al: Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration. Nucleic Acids Res. 46:6576–6591. 2018.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wen M, Hu F, Gong Z, Huang C and Cheng X: HIF‑1α mediates the protective effect of plasma extracellular particles induced by remote ischaemic preconditioning on oxidative stress injury in human umbilical vein endothelial cells. Exp Ther Med 23: 48, 2022.
APA
Wen, M., Hu, F., Gong, Z., Huang, C., & Cheng, X. (2022). HIF‑1α mediates the protective effect of plasma extracellular particles induced by remote ischaemic preconditioning on oxidative stress injury in human umbilical vein endothelial cells. Experimental and Therapeutic Medicine, 23, 48. https://doi.org/10.3892/etm.2021.10970
MLA
Wen, M., Hu, F., Gong, Z., Huang, C., Cheng, X."HIF‑1α mediates the protective effect of plasma extracellular particles induced by remote ischaemic preconditioning on oxidative stress injury in human umbilical vein endothelial cells". Experimental and Therapeutic Medicine 23.1 (2022): 48.
Chicago
Wen, M., Hu, F., Gong, Z., Huang, C., Cheng, X."HIF‑1α mediates the protective effect of plasma extracellular particles induced by remote ischaemic preconditioning on oxidative stress injury in human umbilical vein endothelial cells". Experimental and Therapeutic Medicine 23, no. 1 (2022): 48. https://doi.org/10.3892/etm.2021.10970
Copy and paste a formatted citation
x
Spandidos Publications style
Wen M, Hu F, Gong Z, Huang C and Cheng X: HIF‑1α mediates the protective effect of plasma extracellular particles induced by remote ischaemic preconditioning on oxidative stress injury in human umbilical vein endothelial cells. Exp Ther Med 23: 48, 2022.
APA
Wen, M., Hu, F., Gong, Z., Huang, C., & Cheng, X. (2022). HIF‑1α mediates the protective effect of plasma extracellular particles induced by remote ischaemic preconditioning on oxidative stress injury in human umbilical vein endothelial cells. Experimental and Therapeutic Medicine, 23, 48. https://doi.org/10.3892/etm.2021.10970
MLA
Wen, M., Hu, F., Gong, Z., Huang, C., Cheng, X."HIF‑1α mediates the protective effect of plasma extracellular particles induced by remote ischaemic preconditioning on oxidative stress injury in human umbilical vein endothelial cells". Experimental and Therapeutic Medicine 23.1 (2022): 48.
Chicago
Wen, M., Hu, F., Gong, Z., Huang, C., Cheng, X."HIF‑1α mediates the protective effect of plasma extracellular particles induced by remote ischaemic preconditioning on oxidative stress injury in human umbilical vein endothelial cells". Experimental and Therapeutic Medicine 23, no. 1 (2022): 48. https://doi.org/10.3892/etm.2021.10970
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team